Substance use, self-rated health and HIV status in Brazil

Datos Bibliográficos

ID19444501
AutoresRaquel Brandini De Boni (0000-0002-2455-5997, ICICT, FIOCRUZ, Rio de Janeiro, Brazil, autor de correspondencia), Mauricio Teixeira Leite De Vasconcellos (0000-0003-1658-2589, Brazilian Institute of Geography and Statistics), Nascimento Silva Pedro Luis (Brazilian Institute of Geography and Statistics), Karollaynne Madonna Louise e Silva (Brazilian Institute of Geography and Statistics), Neilane Bertoni Dos Reis (0000-0002-2539-9965, Brazilian National Cancer Institute, Ministry of Health, Rio de Janeiro, Brazil), Neilane Bertoni, Carolina Coutinho (0000-0002-9005-8171, Fundação Getulio Vargas), Carolina F S Coutinho (Fundação Getulio Vargas), Jurema Correa Mota (0000-0002-5007-1590, ICICT, FIOCRUZ, Rio de Janeiro, Brazil), Francisco I Bastos (0000-0001-5970-8896, ICICT, FIOCRUZ, Rio de Janeiro, Brazil)
Año2021
Volumen33
Número10
Páginas1358-1362
Fecha de publicación2021-10-03
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaAIDS Care (JOURNAL)
Identificadores de la revistaISSN: 0954-0121 • E-ISSN: 1360-0451
EditorialInforma UK Limited (PUBLISHER • GB)
DOI10.1080/09540121.2020.1799923
PMID32741210
OpenAlexW3046368092
IdiomaEN
Citas recibidas3
Referencias citadas20

We compared the prevalence of of non-injecting drug use (NIDU) and Self-Rated Health (SRH) among individuals self-reporting as HIV-positive (PLWHA), HIV-negative and unknown at the III Brazilian Household Survey on Substance Use. Overall, 16,273 individuals, 12–65 years old, were interviewed in 2015. Prevalence and Standard Error (SE) were estimated considering the complex sample design and weight calibration. Chi-square tests with Rao-Scott adjustment were used to test independence between NIDU, SRH and HIV status. PLWHA presented higher frequencies of 12-month use for most substances than those reporting to be HIV-negative: alcohol use prevalence was 49.5% (SE 12.8) vs. 43.1% (SE 0.7), p = 0.34; tobacco 45.3% (SE 12.7) vs. 15.3% (SE 0.4), p < 0.01; amphetamines 1.7% (SE 1.7) vs. 0.3% (SE 0.1), p = 0.51; cannabis 10.5%(SE 6.7) vs. 2.5%(0.2), p = 0.06; powder cocaine 3.6% (SE 3.0) vs. 0.9% (SE 0.1), p = 0.45; crack-cocaine 5.3% (SE 3.2) vs. 0.3% (SE 0.1), p < 0.01; inhalants 3.6% (SE 3.0) vs. 0.2% (SE 0), p = 0.03; ketamine 1.7%(SE 1.7) vs. 0.1% (SE 0), p = 0.23; and opioids 1.7% (SE 1.7) vs. 1.4% (SE 0.2), p = 0.93. PLWHA also reported worse SRH. Our results and the scarcity of integrated substance use and HIV treatments call for innovative, cost-effective approaches to tackle these public health challenges

Biology · Cannabis · Intoxicative inhalant · Psychiatry · Substance abuse · Demography · HIV-related health complications and treatments · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Immunology · Toxicology